Search research articles
Contact Us
Filters
Showing results (91-100 of 203) with videos related to
Page
of 21
Sort By:
Journal of Clinical Psychopharmacology
|
February 14, 2015
Relationship between symptomatic improvement and overall illness severity in patients with schizophrenia
Gagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 27, 2019
Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
Hideaki Tani, Shotaro Takasu, Hiroyuki Uchida, et al.
Psychiatry Research
|
May 4, 2015
Optimization of psychopharmacotherapy for schizophrenia in a male, locked, non-acute unit serving for persistently ill patients over one year
Takefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, et al.
International Clinical Psychopharmacology
|
September 27, 2022
Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study
Masaru Tsukahara, Ryuhei So, Shinichiro Nakajima, et al.
Neuropsychopharmacology Reports
|
November 4, 2022
Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data
Takashi Tsujii, Hitoshi Sakurai, Hiroyoshi Takeuchi, et al.
Journal of Clinical Psychopharmacology
|
June 10, 2014
Lack of effect of risperidone or olanzapine dose reduction on metabolic parameters, prolactin, and corrected QT interval in stable patients with schizophrenia
Hiroyoshi Takeuchi, Takefumi Suzuki, Gary Remington, et al.
Schizophrenia Research
|
September 11, 2021
Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms
Yutaro Shimomura, Yuhei Kikuchi, Takefumi Suzuki, et al.
Journal of Psychosomatic Research
|
November 12, 2021
Clinical features of catatonic non-convulsive status epilepticus: A systematic review of cases
Kamiyu Ogyu, Shin Kurose, Hiroyuki Uchida, et al.
International Journal of Geriatric Psychiatry
|
August 16, 2016
Prescription patterns for depression among consultation-liaison psychiatrists and non-psychiatrists: a chart review
Saeko Ikai, Takefumi Suzuki, Hiroyuki Uchida, et al.
The Journal of Clinical Psychiatry
|
February 25, 2017
Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial
Hiroyoshi Takeuchi, Jimmy Lee, Gagan Fervaha, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 203) with videos related to
Sort By:
Page
of 21
Journal of Clinical Psychopharmacology
|
February 14, 2015
Relationship between symptomatic improvement and overall illness severity in patients with schizophrenia
Gagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 27, 2019
Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
Hideaki Tani, Shotaro Takasu, Hiroyuki Uchida, et al.
Psychiatry Research
|
May 4, 2015
Optimization of psychopharmacotherapy for schizophrenia in a male, locked, non-acute unit serving for persistently ill patients over one year
Takefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, et al.
International Clinical Psychopharmacology
|
September 27, 2022
Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study
Masaru Tsukahara, Ryuhei So, Shinichiro Nakajima, et al.
Neuropsychopharmacology Reports
|
November 4, 2022
Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data
Takashi Tsujii, Hitoshi Sakurai, Hiroyoshi Takeuchi, et al.
Journal of Clinical Psychopharmacology
|
June 10, 2014
Lack of effect of risperidone or olanzapine dose reduction on metabolic parameters, prolactin, and corrected QT interval in stable patients with schizophrenia
Hiroyoshi Takeuchi, Takefumi Suzuki, Gary Remington, et al.
Schizophrenia Research
|
September 11, 2021
Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms
Yutaro Shimomura, Yuhei Kikuchi, Takefumi Suzuki, et al.
Journal of Psychosomatic Research
|
November 12, 2021
Clinical features of catatonic non-convulsive status epilepticus: A systematic review of cases
Kamiyu Ogyu, Shin Kurose, Hiroyuki Uchida, et al.
International Journal of Geriatric Psychiatry
|
August 16, 2016
Prescription patterns for depression among consultation-liaison psychiatrists and non-psychiatrists: a chart review
Saeko Ikai, Takefumi Suzuki, Hiroyuki Uchida, et al.
The Journal of Clinical Psychiatry
|
February 25, 2017
Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial
Hiroyoshi Takeuchi, Jimmy Lee, Gagan Fervaha, et al.
Page
of 21